These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19932351)

  • 1. Occlusion of left atrial appendage to treat atrial fibrillation.
    Calvert PA; Rana BS; Begley DA; Shapiro LM
    Lancet; 2009 Nov; 374(9703):1742-3; author reply 1743. PubMed ID: 19932351
    [No Abstract]   [Full Text] [Related]  

  • 2. Left atrial appendage closure device in atrial fibrillation.
    Giudici MC; Bhave PD
    Card Electrophysiol Clin; 2015 Sep; 7(3):415-8. PubMed ID: 26304520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial appendage occlusion eliminates the need for warfarin.
    Holmes DR; Schwartz RS
    Circulation; 2009 Nov; 120(19):1919-26; discussion 1926. PubMed ID: 19901202
    [No Abstract]   [Full Text] [Related]  

  • 4. Left atrial appendage occlusion does not eliminate the need for warfarin.
    Whitlock RP; Healey JS; Connolly SJ
    Circulation; 2009 Nov; 120(19):1927-32; discussion 1932. PubMed ID: 19901203
    [No Abstract]   [Full Text] [Related]  

  • 5. Left atrial appendage occlusion devices versus pharmacological agents for stroke prevention in atrial fibrillation: testing the noninferiority margins.
    Messori A; Fadda V; Maratea D; Trippoli S
    JACC Cardiovasc Interv; 2014 Aug; 7(8):942-3. PubMed ID: 25147042
    [No Abstract]   [Full Text] [Related]  

  • 6. Left atrial appendage occlusion in non-valvular atrial fibrillation.
    McCabe DJ; Kinsella JA; Tobin WO
    Lancet; 2009 Aug; 374(9689):504-6. PubMed ID: 19683627
    [No Abstract]   [Full Text] [Related]  

  • 7. WATCHMAN matches warfarin.
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):456. PubMed ID: 19419252
    [No Abstract]   [Full Text] [Related]  

  • 8. Left atrial appendage occlusion--closure or just the beginning?
    Maisel WH
    N Engl J Med; 2009 Jun; 360(25):2601-3. PubMed ID: 19474420
    [No Abstract]   [Full Text] [Related]  

  • 9. Left Atrial Appendage Occlusion Devices Versus Pharmacological Agents for Stroke Prevention in Atrial Fibrillation.
    Messori A; Trippoli S
    J Am Coll Cardiol; 2015 Nov; 66(18):2056-2058. PubMed ID: 26516013
    [No Abstract]   [Full Text] [Related]  

  • 10. The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial.
    Fountain RB; Holmes DR; Chandrasekaran K; Packer D; Asirvatham S; Van Tassel R; Turi Z
    Am Heart J; 2006 May; 151(5):956-61. PubMed ID: 16644311
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply: Left Atrial Appendage Occlusion Devices Versus Pharmacological Agents for Stroke Prevention in Atrial Fibrillation.
    Holmes DR
    J Am Coll Cardiol; 2015 Nov; 66(18):2058. PubMed ID: 26516014
    [No Abstract]   [Full Text] [Related]  

  • 12. Left Atrial Appendage Occlusion With New Watchman-FLX Device.
    Garg J; Shah K; Shah S; Turagam MK; Natale A; Lakkireddy D
    Am J Cardiol; 2021 Sep; 154():135-137. PubMed ID: 34330451
    [No Abstract]   [Full Text] [Related]  

  • 13. A new approach: Left atrial appendage occlusion, as an alternative to anticoagulant, to treat patient who suffered of atrial fibrillation, acute coronary syndrome and clopidogrel resistance.
    Pankert M; Salaun E; Cuisset T; Bonnet JL
    Int J Cardiol; 2016 Jan; 202():900-3. PubMed ID: 26479956
    [No Abstract]   [Full Text] [Related]  

  • 14. Left Atrial Appendage Closure to Reduce the Risk of Thromboembolic Complications in Atrial Fibrillation: Pay Now and Possibly Pay Later?
    Waks JW; Manning WJ
    J Am Coll Cardiol; 2015 Jun; 65(24):2624-2627. PubMed ID: 26088301
    [No Abstract]   [Full Text] [Related]  

  • 15. Percutaneous left atrial appendage closure in a patient with atrial fibrillation.
    Block PC
    Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):456-9; quiz 460. PubMed ID: 16874358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Patients With Atrial Fibrillation.
    Beaser AD; Cifu AS
    JAMA; 2019 Mar; 321(11):1100-1101. PubMed ID: 30874742
    [No Abstract]   [Full Text] [Related]  

  • 17. [Atrial appendage occlusion in atrial fibrillation? Con].
    Schellinger PD; Köhrmann M
    Nervenarzt; 2015 Oct; 86(10):1275-6. PubMed ID: 26311332
    [No Abstract]   [Full Text] [Related]  

  • 18. [Atrial appendage occlusion in atrial fibrillation? Pro].
    Häusler KG; Landmesser U; Endres M
    Nervenarzt; 2015 Oct; 86(10):1273-4. PubMed ID: 25940442
    [No Abstract]   [Full Text] [Related]  

  • 19. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.
    Yan BP; Kiernan TJ; Gonzales-Cruz I; Lam YY
    Expert Rev Med Devices; 2009 Nov; 6(6):611-20. PubMed ID: 19911873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter left atrial appendage closure for stroke prevention among atrial fibrillation patients.
    Khattab AA; Meier B
    Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):819-21. PubMed ID: 22908912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.